Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ELMD Electromed	$18.93 -1.3%	$19.68	$13.74 ▼ $35.56	$158.75M	0.38	83,048 shs	63,582 shs
EYES Second Sight Medical Products		$5.67	$3.42 ▼ $12.72	$54.38M	2.55	132,982 shs	36,800 shs
NRXS NeurAxis	$2.41 +1.7%	$2.52	$1.33 ▼ $6.20	$17.39M	3.1	677,969 shs	29,041 shs
QTI QT Imaging	$2.03 +1.5%	$1.52	$0.35 ▼ $0.84	$55.08M	-0.2	183,964 shs	33,479 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ELMD Electromed	-1.25%	+1.56%	+2.77%	-12.16%	+31.92%
EYES Second Sight Medical Products	0.00%	0.00%	0.00%	0.00%	0.00%
NRXS NeurAxis	+1.69%	-2.03%	+1.69%	+7.11%	-23.41%
QTI QT Imaging	+0.50%	+8.70%	+16.96%	+163.16%	+299.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ELMD Electromed	1.335 of 5 stars	2.0	3.0	0.0	0.0	0.6	1.7	1.3
EYES Second Sight Medical Products	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	2.852 of 5 stars	3.5	3.0	0.0	0.0	2.4	3.3	0.0
QTI QT Imaging	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ELMD Electromed	4.00	Strong Buy	$33.50	76.97% Upside
EYES Second Sight Medical Products	0.00	N/A	N/A	N/A
NRXS NeurAxis	3.00	Buy	$7.00	190.46% Upside
QTI QT Imaging	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest EYES, ELMD, NRXS, and QTI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/22/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00
7/21/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$7.00

(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ELMD Electromed	$61.44M	2.58	$0.46 per share	41.36	$5.10 per share	3.71
EYES Second Sight Medical Products	$3.38M	0.00	N/A	N/A	$4.80 per share	0.00
NRXS NeurAxis	$2.93M	5.93	N/A	N/A	($0.27) per share	-8.93
QTI QT Imaging	$4.00M	13.78	N/A	N/A	($1.91) per share	-1.06

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ELMD Electromed	$5.15M	$0.79	25.24	∞	N/A	11.34%	15.71%	13.37%	N/A
EYES Second Sight Medical Products	-$8.92M	N/A	0.00	N/A	N/A	N/A	-13.58%	-13.02%	N/A
NRXS NeurAxis	-$14.63M	-$0.99	N/A	∞	N/A	-492.76%	N/A	-641.25%	N/A
QTI QT Imaging	-$4.03M	N/A	0.00	∞	N/A	N/A	N/A	-65.94%	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
EYES Second Sight Medical Products	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	N/A	N/A	N/A	N/A	N/A
QTI QT Imaging	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ELMD Electromed	N/A	5.10	4.74
EYES Second Sight Medical Products	N/A	22.15	22.15
NRXS NeurAxis	N/A	0.24	0.23
QTI QT Imaging	N/A	1.06	0.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ELMD Electromed	40.82%
EYES Second Sight Medical Products	N/A
NRXS NeurAxis	11.77%
QTI QT Imaging	24.19%

Insider Ownership

Company	Insider Ownership
ELMD Electromed	14.00%
EYES Second Sight Medical Products	47.20%
NRXS NeurAxis	26.40%
QTI QT Imaging	75.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ELMD Electromed	160	8.39 million	7.36 million	Optionable
EYES Second Sight Medical Products	15	13.14 million	6.94 million	Optionable
NRXS NeurAxis	19	7.22 million	6.09 million	Not Optionable
QTI QT Imaging	N/A	27.13 million	6.68 million	N/A

EYES, ELMD, NRXS, and QTI Headlines

Recent News About These Companies

QT Imaging Announces Continuous Strong Revenue Growth and Enhanced Balance Sheet in the Second Quarter 2025

August 7, 2025 | finance.yahoo.com

QT Imaging Launches QTviewer 2.8 to Enhance Clinical Efficiency and Diagnostic Accuracy

July 17, 2025 | businesswire.com

QT Imaging Bolsters Medical and Clinical Leadership with Senior Appointments to Further Drive Innovation and Clinical Adoption

July 8, 2025 | finance.yahoo.com

QT Imaging to Hold Virtual 2025 Annual Meeting of Stockholders on August 19

July 3, 2025 | businesswire.com

QT Imaging Leverages NVIDIA L40 GPU Acceleration to Power its Next-Gen Breast Imaging Reconstruction Software

June 25, 2025 | tmcnet.com

Ladenburg Thalmann Initiates Coverage of QT Imaging Holdings (QTIH) with Buy Recommendation

May 20, 2025 | msn.com

QT Imaging Holdings Delivers Its Breast Imaging Scanner to Innovative Radiology in Des Moines, Iowa

May 15, 2025 | finance.yahoo.com

QT Imaging Holdings Announces $200,000 PIPE Investment

May 14, 2025 | joplinglobe.comJ

QT Imaging Announces First Quarter 2025 Financial Results

May 13, 2025 | businesswire.com

QT Imaging Approves Executive Stock Options Plan

April 23, 2025 | tipranks.com

QT Imaging Holdings Announces $500,000 Insiders PIPE Investment

April 10, 2025 | businesswire.com

QT Imaging Holdings Announces $500,000 Insiders PIPE Investment

April 10, 2025 | businesswire.com

QT Imaging Holdings to Participate in the 2025 SBI Breast Imaging Symposium

April 8, 2025 | businesswire.com

QT Imaging Announces Fourth Quarter and Full Year 2024 Financial Results and Provides 2025/26 Outlook

April 2, 2025 | seekingalpha.com

QT Imaging Holdings Announces Shipment of Six QT Breast Acoustic CT Scanners in the First Quarter of 2025

April 1, 2025 | businesswire.com

QT Imaging Holdings Receives $10.1 Million in New Funding to Support Working Capital and Retire Debt

February 27, 2025 | businesswire.com

QTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024

February 14, 2025 | investorplace.com

QT Imaging Holdings Inc. secures sublease agreement

January 24, 2025 | msn.com

QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time

January 15, 2025 | joplinglobe.comJ

QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

January 13, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

EYES, ELMD, NRXS, and QTI Company Descriptions

Electromed NYSE:ELMD

$18.93 -0.24 (-1.25%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$18.86 -0.07 (-0.34%)

As of 08/15/2025 04:04 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Second Sight Medical Products NASDAQ:EYES

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

NeurAxis NASDAQ:NRXS

$2.41 +0.04 (+1.69%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$2.40 -0.01 (-0.41%)

As of 08/15/2025 06:11 PM Eastern

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

QT Imaging NASDAQ:QTI

$2.03 +0.03 (+1.50%)

As of 08/15/2025

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time